Antimicrobial Compounds Targeting Multi-Resistant Bacteria
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The increasing resistance of microorganisms to conventional antimicrobials, particularly multi-resistant gram-negative bacteria, poses challenges in diagnosis and treatment, as existing antimicrobial agents often fail to effectively target these pathogens, leading to incorrect diagnostics and reduced efficacy.
Innovation Solution
Development of new antimicrobial compounds with specific structures, such as β-chloro-L-alanyl-L-1-aminoethylphosphonic acid and its derivatives, which selectively inhibit the growth of target microorganisms like Salmonella and Staphylococcus aureus, while minimizing interference with commensal flora, thereby improving diagnostic specificity and treatment efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antimicrobials are used to treat multi-resistant bacteria, then treatment of common bacterial infections is effective, but they fail to effectively target multi-resistant gram-negative bacteria leading to treatment failure
Solution Approach 1:
The patent modifies the chemical structure of existing antimicrobial agents by introducing specific substitutions and modifications to the core molecular framework, creating derivatives with enhanced activity against multi-resistant bacteria while maintaining efficacy against common pathogens
Solution Approach 2:
The invention combines multiple functional moieties within a single molecular structure, integrating elements that provide both broad-spectrum activity and specific anti-resistance properties, effectively creating a composite antimicrobial agent
2Measurement precision
If selective culture media containing inhibitors are used to isolate target microorganisms, then detection specificity improves, but multi-resistant microorganisms can give rise to erroneous diagnostics generating false-positive results
Solution Approach 1:
The patent develops new antimicrobial compounds with modified chemical parameters that allow selective culture media to distinguish between multi-resistant organisms and true pathogens, reducing false positives while maintaining diagnostic specificity
Solution Approach 2:
The invention introduces novel antimicrobial agents as intermediary substances in culture media that selectively inhibit multi-resistant commensals without affecting target pathogens, thereby mediating between the need for selectivity and diagnostic accuracy
3Reliability
If new antimicrobial compounds are developed to target multi-resistant bacteria, then treatment efficacy against these pathogens improves, but the complexity of drug development and testing increases
Solution Approach 1:
The patent systematically divides the drug development process into discrete stages with clearly defined objectives and criteria, allowing for methodical progression from compound synthesis to clinical evaluation while managing complexity
Solution Approach 2:
The invention employs systematic modification of molecular parameters and physical-chemical properties of candidate compounds to optimize activity against multi-resistant bacteria while maintaining acceptable safety profiles and pharmacokinetic characteristics
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These compounds demonstrate enhanced antibacterial activity against multi-resistant bacteria, including carbapenemase-producing strains, with improved specificity and potency compared to traditional antimicrobials, facilitating more accurate diagnostics and effective treatments.
Implementation Method 1
new antimicrobial compounds... proving to be effective against microorganisms which are multi-resistant to antimicrobials
Implementation Method 2
selectively inhibit the growth of target microorganisms like Salmonella and Staphylococcus aureus, while minimizing interference with commensal flora
Data Source
AI summary
An antimicrobial compound, as well as the salts, derivatives and analogs thereof, said compound being represented by the general formula (I):wherein R1 represents a peptide part P1 or a peptide part P2.